13 Best Hot Stocks to Buy According to Analysts

In this article, we will discuss the 13 Best Hot Stocks to Buy According to Analysts.

On March 6, Dan Niles, Niles Investment Management founder, joined ‘Power Lunch’ on CNBC to discuss the broader market sell-off and provide a cautious outlook on the current market environment. Addressing the broader sell-off triggered by the conflict involving Iran, Niles emphasized that the primary concern for investors is the duration of the war. While a short-term conflict of less than a month might be manageable, a long-term engagement could drive oil prices above $100, potentially leading to a global recession.

Niles observed a counterintuitive trend where software and the Mag 7 have outperformed since the conflict began. He defended his recent bullish stance on a software rally and noted that even with negative industry commentary and significant AI-driven layoffs, the software index still finished a recent week up 1% while the S&P 500 fell 0.4%. He argued that even if software faces a long-term decline similar to the 2001–2002 period, history shows that such cycles include massive countertrend rallies that can average 14% over two months.

Responding to concerns about market complacency and commodity shortages, Niles asserted that price leads the narrative, meaning that the market’s reaction to news is more telling than the news itself. While his personal belief is that stocks should be lower, he acknowledged that the market is signaling a potential resolution to the conflict. He advised investors to be hyper-selective and to get messy by diversifying into sectors with heavy assets that are less prone to AI-driven obsolescence.

Our Methodology

We used screeners to identify stocks that have gained at least 90% over the past 6 months and had an average upside potential of at least 30%. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Note: All data was sourced on March 16. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

13 Best Hot Stocks to Buy According to Analysts

13. Praxis Precision Medicines Inc. (NASDAQ:PRAX)

Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best hot stocks to buy according to analysts. On February 19, Praxis Precision Medicines reported the financial results for Q4 2025, ending 2025 with $926 million in cash & investments. Following an additional $621 million financing in January, the company’s cash runway is now expected to fund operations into 2028. While R&D expenses rose to $267.1 million for the full year due to intensified clinical activity, the company has also expanded its leadership team and Board of Directors to support its upcoming commercial launches and long-term clinical strategy.

Praxis Precision Medicines Inc. (NASDAQ:PRAX) submitted two NDAs to the FDA for ulixacaltamide, aimed at treating essential tremor, and relutrigine, for specific pediatric epileptic encephalopathies. Both therapies have received Breakthrough Therapy Designation, with ulixacaltamide notably being the first investigational therapy to show positive Phase 3 results for essential tremor.

The company is advancing several high-potential programs through its Cerebrum and Solidus platforms. Vormatrigine, a potent sodium-channel modulator for epilepsy, is expected to yield Phase 3 topline results in Q2 2026, while the antisense oligonucleotide elsunersen is on track for Phase 1/2 results in H1 2026. Beyond its late-stage assets, Praxis Precision Medicines intends to nominate three new development candidates by mid-2026 to address conditions such as autism spectrum disorders and intellectual disabilities, with regulatory submissions planned for the next two years.

Praxis Precision Medicines Inc. (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company that develops therapies for central nervous system/CNS disorders characterized by neuronal excitation-inhibition imbalance in the US.

12. Spruce Biosciences Inc. (NASDAQ:SPRB)

Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the best hot stocks to buy according to analysts. On March 9, Spruce Biosciences appointed Dale Hooks as Chief Commercial Officer to lead the company’s transition toward its next phase of growth. Hooks brings nearly 35 years of biopharmaceutical experience to the role, having overseen 21 new product launches throughout his career. His background includes leadership positions at Reata Pharmaceuticals, where he managed one of the most successful rare disease launches in US history, as well as executive roles at Applied Therapeutics, Clovis Oncology, and Genentech.

The appointment comes as Spruce Biosciences Inc. (NASDAQ:SPRB) prepares for the planned BLA submission for tralesinidase alfa/TA-ERT, an enzyme replacement therapy for Sanfilippo Syndrome Type B/MPS IIIB. The CEO emphasized that Hooks’ expertise in building launch-ready infrastructure and commercial strategy will be critical as the company advances what could be the first disease-modifying treatment for this rare neurological disorder.

In his new role, Hooks will be responsible for shaping the commercial strategy and building high-performing teams to support the potential market entry of TA-ERT. He joins a leadership team currently focused on addressing significant unmet medical needs within the rare disease community.

Spruce Biosciences Inc. (NASDAQ:SPRB) is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

11. Capricor Therapeutics Inc. (NASDAQ:CAPR)

Capricor Therapeutics Inc. (NASDAQ:CAPR) is one of the best hot stocks to buy according to analysts. On March 12, Capricor Therapeutics presented new late-breaking data from its Phase 3 HOPE-3 clinical trial at the 2026 MDA Conference, highlighting the benefits of Deramiocel for Duchenne muscular dystrophy. Cardiac MRI results showed a reduction in myocardial fibrosis compared to the placebo group, with a notable improvement in left ventricular ejection fraction among patients with baseline cardiomyopathy. Additionally, a composite Global Statistical Test confirmed a statistically significant overall treatment benefit, integrating measures of physical function and patient perspective.

Functional outcomes also demonstrated that Deramiocel significantly slows disease progression related to daily activities. Data from the Duchenne Video Assessment specifically showed an 83% slowing of progression in tasks such as independent eating, which correlates with improved elbow and arm function observed in clinical testing. These findings suggest the therapy may help preserve patient independence by maintaining critical hand-to-mouth movements over time.

Capricor Therapeutics Inc. (NASDAQ:CAPR) is currently moving toward potential commercialization, with a BLA under FDA review. Deramiocel has already received several special designations, including Orphan Drug and Regenerative Medicine Advanced Therapy status. The FDA has set a PDUFA target action date of August 22 to decide on the therapy’s approval for the US market.

Capricor Therapeutics Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company that develops transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy/DMD and other diseases with unmet medical needs in the US.

10. Babcock & Wilcox Enterprises Inc. (NYSE:BW)

Babcock & Wilcox Enterprises Inc. (NYSE:BW) is one of the best hot stocks to buy according to analysts. On March 4, Babcock & Wilcox reported results for Q4 2025, with revenue of $161 million and a significant improvement in operating income, which rose to $12.2 million from $2.6 million in the prior year’s quarter. Full-year 2025 results show consolidated revenues of $587.7 million. These gains were supported by a 17% increase in parts & services revenue, driven by higher baseload demand and increased coal generation usage in North America. The company also narrowed its full-year loss from continuing operations to $32.8 million, down from $104.3 million in 2024.

The company announced a major strategic shift with a full notice to proceed on a $2.4 billion project for Base Electron, backed by Applied Digital. This initiative involves providing 1.2 GW of natural gas technology for AI Factory campuses, driving the company’s continuing operations backlog to $2.8 billion, a 470% increase compared to the end of 2024. This project, combined with a global pipeline that now exceeds $12 billion, positions Babcock & Wilcox as a key player in the high-capacity energy generation market required to support the rapid growth of AI and data center infrastructure.

The CEO noted that the company is uniquely positioned to capitalize on global demand for baseload generation, benefiting from Department of Energy mandates and the need for faster power solutions amid combustion turbine delays. Babcock & Wilcox Enterprises Inc. (NYSE:BW) remains focused on converting its robust project pipeline into sustained growth as it enters 2026.

Babcock & Wilcox Enterprises Inc. (NYSE:BW), together with its subsidiaries, provides energy and emissions control solutions to industrial, electrical utility, municipal, and other customers in the US, Canada, the UK, Indonesia, and the Philippines.

9. Nova Minerals Limited (NASDAQ:NVA)

Nova Minerals Limited (NASDAQ:NVA) is one of the best hot stocks to buy according to analysts. On March 9, Nova Minerals reported high-grade gold assay results from its 2025 surface sampling program at the RPM project, part of the Estelle Gold and Critical Minerals Project in Alaska. The program identified new gold anomalies to the west of the existing site and along the northern end of the RPM ridgeline. Key findings include rock samples grading up to 24.6 g/t Au and soil samples peaking at 5.5 g/t Au, building upon previous reconnaissance that returned values as high as 52.3 g/t Au.

Nova Minerals Limited (NASDAQ:NVA) designated the RPM ridgeline as a high-priority drill target for its 2026 exploration season. Technical data from drone magnetometry and geochemical sampling suggest that the northern extension of the ridge shares similar magnetic signatures and geological characteristics with the main RPM deposit. Geologists noted that the gold was found within stockwork quartz veining in both intrusive and hornfels host rocks, supporting the potential for high-grade pods similar to those previously discovered at RPM North.

Success at these new anomalies could provide significant upside for the broader Estelle Project, particularly due to their proximity to established access routes. While further investigation is required for the anomalies located to the west, the company intends to return in 2026 to expand on these targets. This upcoming program will focus on systematic drill testing to confirm the scale and grade of these recent surface discoveries.

Nova Minerals Limited (NASDAQ:NVA) explores mineral properties in Australia and the US. The company explores for gold, antimony, and critical minerals.

8. Micropolis AI Robotics (NYSEAMERICAN:MCRP)

Micropolis AI Robotics (NYSEAMERICAN:MCRP) is one of the best hot stocks to buy according to analysts. On March 3, Micropolis Robotics entered into a $9.3 million commercial agreement with AfricAI Limited to develop and distribute autonomous vehicle solutions across Africa. The 18-month development program focuses on creating three custom unmanned ground vehicle/UGV models specifically engineered for African climates and terrains. These platforms will be tailored for applications in police and public safety, agriculture, and border control missions.

The partnership includes a multi-year distribution agreement granting AfricAI exclusive rights within the Economic Community of West African States/ECOWAS, South Africa, the Democratic Republic of Congo, and Tanzania. AfricAI will market both the newly developed custom models and Micropolis’s existing M-Patrol units. The rollout strategy includes real-environment pilot testing at selected sites to validate the technology before full-scale commercialization.

This collaboration aims to accelerate the deployment of AI-driven robotics in high-growth regions where demand for intelligent automation is rising. Micropolis AI Robotics (NYSEAMERICAN:MCRP) leadership noted that the agreement is a strategic step toward international expansion, allowing the company to deliver localized support while strengthening its commercial footprint. The initiative also supports AfricAI’s mission to scale sovereign, context-adapted AI capabilities throughout the continent.

Micropolis AI Robotics (NYSEAMERICAN:MCRP), together with its subsidiary, Micropolis Digital Development FZ-LLC, develops autonomous mobile robots/AMR in the UAE and Saudi Arabia.

7. Americas Gold and Silver Corporation (NYSEAMERICAN:USAS)

Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) is one of the best hot stocks to buy according to analysts. On March 12, Americas Gold and Silver Corporation announced the discovery of ten new high-grade veins at the Galena Complex, including 7 silver-copper-antimony veins and 3 silver-lead veins. These discoveries, resulting from late 2025 exploration, feature silver grades significantly higher than the project’s current mineral resources and reserves. Notable drill results include 4,896 g/t silver and 3.95% copper over 1.3 meters, as well as 2,563 g/t silver and 1.35% antimony over 0.7 meters.

Following these results, Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) approved the largest drilling campaign in its history for 2026, totaling ~64,000 meters. This program will span operations in Idaho and Mexico, including the Galena Complex and the Cosalá site. A key component of the campaign involves mobilizing underground and surface rigs to the recently acquired Crescent Mine, a high-grade past producer that has not undergone systematic drilling in decades.

The exploration strategy targets numerous parallel and splay veins located near active mine workings, which the company views as immediate growth opportunities. Management indicated that these discoveries highlight the untapped potential of the Galena Complex after 120 years of operation. By investing in these high-grade discoveries, the company aims to support its current growth trajectory and strengthen its position as a North American precious metals and antimony producer.

Americas Gold and Silver Corporation (NYSEAMERICAN:USAS), together with its subsidiaries, explores, develops, and produces mineral properties in the Americas. The company explores for gold, silver, zinc, lead, and other by-products.

6. Blue Moon Metals Inc. (NASDAQ:BMM)

Blue Moon Metals Inc. (NASDAQ:BMM) is one of the best hot stocks to buy according to analysts. On March 16, Blue Moon Metals finalized the acquisition of the Apex Mine from Teck American Incorporated, which is a subsidiary of Teck Resources Limited. Following the initial announcement in February, the transaction received TSX-V approval and resulted in Teck holding an 8.0% undiluted interest in Blue Moon through the issuance of over 7 million common shares. The acquired property consists of 24 patented and 9 unpatented claims focused on germanium and gallium production.

As part of the closing terms, Blue Moon granted Teck a 0.5% net smelter returns/NSR royalty on the property and assumed an existing 3.0% NSR royalty obligation. Additionally, both parties entered into an investor rights agreement that provides Teck with equity participation, top-up, and information rights. The companies also established a life-of-mine zinc off-take agreement for the Blue Moon Mine, with terms and treatment charges set according to current industry benchmarks.

The previously disclosed marketing agreement has been replaced by a formal off-take agreement for the Apex Mine claims. Under this arrangement, Teck will pay Blue Moon Metals Inc. (NASDAQ:BMM) the market value of the produced materials, less a fixed percentage, with the specific market value to be reassessed on an annual basis. The transaction was conducted at arm’s length, and no finder’s fees were paid in connection with the deal.

Blue Moon Metals Inc. (NASDAQ:BMM) explores and develops mineral resource properties in Norway and the US. The company explores for zinc, silver, gold, lead, germanium, gallium, and copper deposits.

Click to continue reading and see the 5 Best Hot Stocks to Buy According to Analysts.

Disclosure: None. None. Follow Insider Monkey on Google News.